Results 121 to 130 of about 13,248 (184)

Phenotypic and biochemical characterization of the class C β-lactamase, PAC-1. [PDF]

J Antimicrob Chemother
Raro OHF, Mancini S, Findlay J, Seth-Smith HMB, Ali Syed M, Egli A, Nordmann P, Poirel L.   +7 more
europepmc   +1 more source

A Ten-Year Trend of Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i> From United States Medical Centers: Results From the INFORM Surveillance Program (2015-2024). [PDF]

Open Forum Infect Dis
Sader HS, Mendes RE, Lock J, Papp-Wallace KM, Castanheira M.   +4 more
europepmc   +1 more source

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies. [PDF]

Antimicrob Agents Chemother
Hernández-García M, Pérez-Viso B, Nieto-Torres M, García-Castillo M, Michelena M, Martínez-Martínez L, Baquero F, Ruiz-Garbajosa P, Cantón R.   +8 more
europepmc   +1 more source

Aztreonam-avibactam therapy following surgical source control for <i>bla</i> _<i>NDM</i> -positive carbapenem-resistant <i>Klebsiella pneumoniae</i> intra-abdominal infection in an infant: a case report. [PDF]

Front Pharmacol
Liu J, He X, Zhao W, Du L, Qiao L, Qing L.   +5 more
europepmc   +1 more source

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? [PDF]

JAC Antimicrob Resist
Assimakopoulos SF, Ioannou S, Rodriguez-Bano J, Marangos M, Daikos GL.   +4 more
europepmc   +1 more source

In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli. [PDF]

Antibiotics (Basel)
Karlowsky JA, Wise MG, Shi Q, Zhang W, Le M, Li J.   +5 more
europepmc   +1 more source

Case Report: Dynamic susceptibility-informed therapy for bile leak-associated intra-abdominal <i>Stenotrophomonas maltophilia</i> infection. [PDF]

Front Med (Lausanne)
Yang Z, Zhu B, Chen J.
europepmc   +1 more source

Characterization of phylogroups of <i>Klebsiella pneumoniae</i> (<i>K. quasipneumoniae</i> and <i>K. variicola</i>) harbouring <i>bla</i> _OXA-232, with special reference to ceftazidime/avibactam/aztreonam synergy and their genetic profile. [PDF]

JAC Antimicrob Resist
Banerjee T, Mishra K, Rakshit P, Yadav G, Kumar A.   +4 more
europepmc   +1 more source

Emergence of ceftazidime-avibactam resistance mediated by KPC variants KPC-71 and KPC-78 in ST463 <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Yang F, Sun Y, Chen W, Shen D, Zhu J, Sun Z, Cai Y, Zhang Y, Shen H, Sun F, Xiao Y, Jiang C, Cui Z.   +12 more
europepmc   +1 more source

<i>In vitro</i> susceptibility testing of aztreonam-avibactam against predominantly NDM-producing <i>Enterobacterales</i> in Peru. [PDF]

Microbiol Spectr
Garcia C, Reyes Y, Astocondor L, Caytuiro L, Riveros M, Amaro C, Andrade S, Hernández L, Sandoval R, Peréz-Lazo G, Cucho C, Melo M, Sabogal I, Lino L, Cuaresma E, Olivares A, Lachira A, Michilot K, Ramos J, Diaz R, Briones A, Burgos S, Cuicapuza D, Tsukayama P, Krapp F.   +24 more
europepmc   +1 more source